image

About Us

This section provides basic information about us

History

2014.04
Closed a contract with post-genome government project (KNIH Korean Chip (KORV1.0) development and analysis)
04
Closed a contract with US GlaxoSmithKline (GSK) for non-clinical study
07
Closed a contract with US The Jackson Laboratory on PDX banking and technical alliance
12
Closed a contract with post-genome government project (development of personal genomics industrialization model based on Ministry of Trade, Industry & Energy (MOTIE) genomic & clinical information)
2013.02
Signed PbA partnership with Affymetrix
07
Launched DNAGPS_M and DNAGPS_W
09
Launched new human identification product (AccuID)
11
Established DNA Link USA, Inc., a local subsidiary in the US.
2012.02
Patent Application (2) for biomarker composition for human identification and its purpose c
03
Registered trademark for AccuID, a SNP-based human identification product/ launched low price & distribution product model for DNAGPS
04
Technology transfer of preventive vaccine for virus and bacteria infection
06
Made an agreement with Seoul National Univ. Hospital Gangnam Center to establish biobank
08
Patent Application for human identification SNP markers and their purpose
09
Made an agreement with SK Chemical for personalized genomic analysis business
2011.01
Closed a contract with illumina as a certified services provider for NGS
02
Contracted with Ernst & Young to establish and internal accounting management structure
03
Patent Application of diagnostic biomarkers and their use for atopic dermatitis
04
Submitted a written request to go public (Korea Exchange)
04
Business cooperation for personal genomic analysis service with Seoul National Univ. Gangnam Center
07
Approval to go public (Korea Exchange)
07
Patent Application of polynucleotide and its use for risk diagnosis of metabolic syndrome of obese individual
08
Introduction of 3rd generation sequencer (Pacific Bioscience)
09
Patent Application of polynucleotide related to the occurrence of coronary artery disease and the method to identify the object which has the altered risk of coronary artery disease occurrence
12
Listed in KOSDAQ / relocation of office to Asan Institute for Life Sciences (Pungnap-dong, Songpa-gu)
2010.01
Patent Application for SNP and its purpose for obesity and/or diabetes
08
Launched DNAGPS, a personalized genomic analysis service
10
Selected by the Military Manpower Administration as an alternative to serving in the military
10
Closed a MOU for joint R&D and sales for DNAGPS (Seoul National Univ. Gangnam Center)
2009.03
Closed a contract with Affymetrix(US) as global service provider
05
Closed a contract as an academic service provider for 2009 Korean Genotype Research business (Korea National Institutes of Health, 1.7 million dollar project)
08
Closed a Contract with Roche NimbleGen(US) as a certified service provider
12
Certified as a INNO-BIZ for technology (the Small and Medium Business Administration)
2008.04
Closed a contract as an academic service provider for 2008 Korean Genotype Research business (Korea National Institutes of Health, 2.7 million dollar project)
04
Performed basic business for Korea Food Research Institute (Korea Food Research Institute, Ministry of Education, Science, and Technology, 8-year project)
04
Attracted Investment and contracted business cooperation with Anguk Pharmaceutical ($500,000)
12
Obtained KOLAS ISO/IEC 17025:2005 certification
2007.05
Small Business Technological Innovation Development business (the Small and Medium Business Administration, 2-year project)
06
Closed a contract as an academic service provider for 2007 Korean Genotype Research business (Korea National Institutes of Health, 2.8 million dollar project)
12
Relocation of Office (Sungsan-dong, Mapo-gu)
2006.05
Closed a contract with Affymetrix(US) as an authorized service provider
07
Selected as an outsource company for DNA identification at the National Police Agency
2005.05
Supervision of development center for genomic-based diagnostic DNA chip development for particular disease group (Ministry of Health & Welfare, 5-year project)
11
Started a joint research with Metabolic Disease Research Center (Yonsei Univ. College of Public Health, the Seoul Metropolitan govt., 5-year project)
2004.12
Obtained ISO 9001 Certification (Genomic Research and Analysis)
2003.05
Started a joint research with Pharmacogenomics Research Network (Seoul Nation Univ. Clinical Medicine Center, Ministry of Health & Welfare, 9-year project)
05
Korean HapMap Project (Korean HapMap Consortium, Ministry of Science and Technology, 5-year project)
2001.05
Launched Lung, Breast, and Ovarian Cancer Research business(Korea Univ., Ministry of Health & Welfare, 10-year project)
12
Execution of Korean SNP Validation Project (National Institute of Health, Ministry of Health & Welfare, 2-year project)
2000.03
Establishment of DNA Link, Inc
05
Establishment of DNA Link, Inc. Genomic Research Center
12
Launched Cardiovascular Disease research business (Yonsei Univ. Cardiac Center, Ministry of Health & Welfare, 10-year project)
12
Launched Liver & Digestive Trouble research business (Aju Univ., Ministry of Health & Welfare, 10-year project)